Literature DB >> 22565942

Industry reels as Prometheus falls and Myriad faces further reviews.

Jeffrey L Fox.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22565942     DOI: 10.1038/nbt0512-373

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Myriad decision reassures biotechs but diagnostics still murky.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2011-09-08       Impact factor: 54.908

  1 in total
  3 in total

1.  Myriad decision aftershocks ripple through biotech.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

2.  Stealing fire: a retrospective survey of biotech patent claims in the wake of Mayo v. Prometheus.

Authors:  Elizabeth J Haanes; Jaume M Cànaves
Journal:  Nat Biotechnol       Date:  2012-08       Impact factor: 54.908

3.  Patenting natural products just got harder.

Authors:  Charlotte Harrison
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.